Suki Wiltman

Vice President, Global Business Ethics at Ipsen Biopharmaceuticals

Speaker

As Vice-President, Global Business Ethics, Suki is driving the evolution and enhancement of the Global Business Ethics strategy within the Global functions of Medical, Research & Development, Tech Ops, Rare Disease and the Canada Affiliate, to guide ethical and compliant decision making and promote an ethical culture. Additionally, she is Leading and driving the continuous improvement of the Global Business Ethics Education & Training, Third Party and Anti-Corruption Programs. Suki has 25+ years of experience in the pharmaceutical industry. Prior to joining Ipsen in 2017, Suki held various roles of increasing responsibility in Ethics & Compliance and Quality at GSK, Allergan, Eli Lilly and Sanofi.